Advertisement
Canada markets open in 8 hours 54 minutes
  • S&P/TSX

    21,788.48
    -60.11 (-0.28%)
     
  • S&P 500

    5,469.30
    +21.43 (+0.39%)
     
  • DOW

    39,112.16
    -299.05 (-0.76%)
     
  • CAD/USD

    0.7322
    -0.0001 (-0.01%)
     
  • CRUDE OIL

    81.24
    +0.41 (+0.51%)
     
  • Bitcoin CAD

    84,349.09
    +601.67 (+0.72%)
     
  • CMC Crypto 200

    1,281.26
    +32.14 (+2.57%)
     
  • GOLD FUTURES

    2,328.80
    -2.00 (-0.09%)
     
  • RUSSELL 2000

    2,022.35
    -8.47 (-0.42%)
     
  • 10-Yr Bond

    4.2380
    -0.0100 (-0.24%)
     
  • NASDAQ futures

    19,987.25
    +15.00 (+0.08%)
     
  • VOLATILITY

    12.84
    -0.49 (-3.68%)
     
  • FTSE

    8,247.79
    -33.76 (-0.41%)
     
  • NIKKEI 225

    39,681.80
    +508.65 (+1.30%)
     
  • CAD/EUR

    0.6834
    +0.0002 (+0.03%)
     

ANGLE Full Year 2023 Earnings: EPS Misses Expectations

ANGLE (LON:AGL) Full Year 2023 Results

Key Financial Results

  • Net loss: UK£20.1m (loss narrowed by 7.2% from FY 2022).

  • UK£0.077 loss per share (improved from UK£0.088 loss in FY 2022).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

ANGLE EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.6%.

Looking ahead, revenue is forecast to grow 47% p.a. on average during the next 3 years, compared to a 6.4% growth forecast for the Medical Equipment industry in the United Kingdom.

Performance of the British Medical Equipment industry.

ADVERTISEMENT

The company's shares are down 20% from a week ago.

Risk Analysis

You still need to take note of risks, for example - ANGLE has 5 warning signs (and 1 which makes us a bit uncomfortable) we think you should know about.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.